The DOI matches its Crossref record; 80 of the 80 references it cites were found in a registry or an index.
Prognostic Significance of Tumor-Associated Macrophages in Solid Tumor: A Meta-Analysis of the Literature
Open accessAbstract
PURPOSE: Tumor associated macrophages (TAMs) are considered with the capacity to have both negative and positive effects on tumor growth. The prognostic value of TAM for survival in patients with solid tumor remains controversial. EXPERIMENTAL DESIGN: We conducted a meta-analysis of 55 studies (n = 8,692 patients) that evaluated the correlation between TAM (detected by immunohistochemistry) and clinical staging, overall survival (OS) and disease free survival (DFS). The impact of M1 and M2 type TAM (n = 5) on survival was also examined. RESULTS: High density of TAM was significantly associated with late clinical staging in patients with breast cancer [risk ratio (RR) = 1.20 (95% confidence interval (CI), 1.14-1.28)] and bladder cancer [RR = 3.30 (95%CI, 1.56-6.96)] and with early clinical staging in patients with ovarian cancer [RR = 0.52 (95%CI, 0.35-0.77)]. Negative effects of TAM on OS was shown in patients with gastric cancer [RR = 1.64 (95%CI, 1.24-2.16)], breast cancer [RR = 8.62 (95%CI, 3.10-23.95)], bladder cancer [RR = 5.00 (95%CI, 1.98-12.63)], ovarian cancer [RR = 2.55 (95%CI, 1.60-4.06)], oral cancer [RR = 2.03 (95%CI, 1.47-2.80)] and thyroid cancer [RR = 2.72 (95%CI, 1.26-5.86)],and positive effects was displayed in patients with colorectal cancer [RR = 0.64 (95%CI, 0.43-0.96)]. No significant effect was showed between TAM and DFS. There was also no significant effect of two phenotypes of TAM on survival. CONCLUSIONS: Although some modest bias cannot be excluded, high density of TAM seems to be associated with worse OS in patients with gastric cancer, urogenital cancer and head and neck cancer, with better OS in patients with colorectal cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bias in meta-analysis detected by a simple, graphical test
Egger, M., Smith, G. D., Schneider, M., & Minder, C. (1997) · BMJ · doi:10.1136/bmj.315.7109.629 · Cited by 56,722
Alternative activation of macrophages
Gordon, S. (2003) · Nature Reviews Immunology · doi:10.1038/nri978 · Cited by 6,189
MANTOVANI, A., SOZZANI, S., LOCATI, M., ALLAVENA, P., & SICA, A. (2002) · Trends in Immunology · doi:10.1016/s1471-4906(02)02302-5 · Cited by 5,528 · cited 1×
“The M1 macrophages are thought to be induced by interferon-c, with or without lipopolysaccharide, tumor necrosis factor (TNF)-a, and activate cells of the adaptive immune system [4].”
BackgroundParmar, M. K. B., Torri, V., & Stewart, L. (1998) · Statistics in Medicine · doi:10.1002/(sici)1097-0258(19981230)17:24<2815::aid-sim110>3.0.co;2-8 · Cited by 4,802
Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm
Biswas, S. K., & Mantovani, A. (2010) · Nature Immunology · doi:10.1038/ni.1937 · Cited by 3,840
Bingle, L., Brown, N. J., & Lewis, C. E. (2002) · The Journal of Pathology · doi:10.1002/path.1027 · Cited by 2,022
Cloning and Characterization of Inducible Nitric Oxide Synthase from Mouse Macrophages
Xie, Q.-W., Cho, H. J., Calaycay, J., Mumford, R. A., Swiderek, K. M., Lee, T. D., Ding, A., Troso, T., & Nathan, C. (1992) · Science · doi:10.1126/science.1373522 · Cited by 1,886
Association of macrophage infiltration with angiogenesis and prognosis in invasive breast carcinoma.
Leek, R., Lewis, C. E., Whitehouse, R. M., Greenall, M. J., Clarke, J., & Harris, A. L. (1996) · PubMed · Cited by 1,187
The origin and function of tumor-associated macrophages
Mantovani, A., Bottazzi, B., Colotta, F., Sozzani, S., & Ruco, L. (1992) · Immunology Today · doi:10.1016/0167-5699(92)90008-u · Cited by 1,089
Kuang, D.-M., Zhao, Q., Peng, C., Xu, J., Zhang, J.-P., Wu, C., & Zheng, L. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20082173 · Cited by 903
Meta-analysis of the literature or of individual patient data: is there a difference?
Stewart, L. A., & Parmar, M. K. B. (1993) · The Lancet · doi:10.1016/0140-6736(93)93004-k · Cited by 769
(2000) · PubMed · Cited by 706
Statistical aspects of prognostic factor studies in oncology
Simon, R., & Altman, D. (1994) · British Journal of Cancer · doi:10.1038/bjc.1994.192 · Cited by 582
High Macrophage Infiltration along the Tumor Front Correlates with Improved Survival in Colon Cancer
Forssell, J., Öberg, A., Henriksson, M. L., Stenling, R., Jung, A., & Palmqvist, R. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-2073 · Cited by 566
Zhu, X.-D., Zhang, J.-B., Zhuang, P.-Y., Zhu, H.-G., Zhang, W., Xiong, Y.-Q., Wu, W.-Z., Wang, L., Tang, Z.-Y., & Sun, H.-C. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.15.6521 · Cited by 556
Ryder, M., Ghossein, R. A., Ricarte-Filho, J. C. M., Knauf, J. A., & Fagin, J. A. (2008) · Endocrine Related Cancer · doi:10.1677/erc-08-0036 · Cited by 443
Ma, J., Liu, L., Che, G., Yu, N., Dai, F., & You, Z. (2010) · BMC Cancer · doi:10.1186/1471-2407-10-112 · Cited by 437
Self-citationIdentification and manipulation of tumor associated macrophages in human cancers
Heusinkveld, M., & van der Burg, S. H. (2011) · Journal of Translational Medicine · doi:10.1186/1479-5876-9-216 · Cited by 435
Kawai, O., Ishii, G., Kubota, K., Murata, Y., Naito, Y., Mizuno, T., Aokage, K., Saijo, N., Nishiwaki, Y., Gemma, A., et al. (2008) · Cancer · doi:10.1002/cncr.23712 · Cited by 384
Tumor-Associated Macrophages: The Double-Edged Sword in Cancer Progression
Chen, J. J. W., Lin, Y.-C., Yao, P.-L., Yuan, A., Chen, H.-Y., Shun, C.-T., Tsai, M.-F., Chen, C.-H., & Yang, P.-C. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.12.172 · Cited by 374
Verreck, F. A. W., de Boer, T., Langenberg, D. M. L., van der Zanden, L., & Ottenhoff, T. H. M. (2005) · Journal of Leukocyte Biology · doi:10.1189/jlb.0105015 · Cited by 373
Welsh, T. J., Green, R. H., Richardson, D., Waller, D. A., O'Byrne, K. J., & Bradding, P. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.01.4910 · Cited by 369
Role of macrophages in tumour progression
Siveen, K. S., & Kuttan, G. (2009) · Immunology Letters · doi:10.1016/j.imlet.2009.02.011 · Cited by 353
Umemura, N., Saio, M., Suwa, T., Kitoh, Y., Bai, J., Nonaka, K., Ouyang, G.-F., Okada, M., Balazs, M., Adany, R., et al. (2008) · Journal of Leukocyte Biology · doi:10.1189/jlb.0907611 · Cited by 346
Lissbrant, I. F., Stattin, P., Wikstrom, P., Damber, J. E., Egevad, L., & Bergh, A. (2000) · International Journal of Oncology · doi:10.3892/ijo.17.3.445 · Cited by 333
Ohri, C. M., Shikotra, A., Green, R. H., Waller, D. A., & Bradding, P. (2009) · European Respiratory Journal · doi:10.1183/09031936.00065708 · Cited by 296
Prognostic value of tumor‐associated macrophage count in human bladder cancer
Hanada, T., Nakagawa, M., Emoto, A., Nomura, T., Nasu, N., & Nomura, Y. (2000) · International Journal of Urology · doi:10.1046/j.1442-2042.2000.00190.x · Cited by 283
Significance of alternatively activated macrophages in patients with intrahepatic cholangiocarcinoma
Hasita, H., Komohara, Y., Okabe, H., Masuda, T., Ohnishi, K., Lei, X. F., Beppu, T., Baba, H., & Takeya, M. (2010) · Cancer Science · doi:10.1111/j.1349-7006.2010.01614.x · Cited by 275
Shimura, S., Yang, G., Ebara, S., Wheeler, T. M., Frolov, A., & Thompson, T. C. (2000) · PubMed · Cited by 271
Tumour-infiltrating macrophages and clinical outcome in breast cancer
Mahmoud, S. M. A., Lee, A. H. S., Paish, E. C., Macmillan, R. D., Ellis, I. O., & Green, A. R. (2012) · Journal of Clinical Pathology · doi:10.1136/jclinpath-2011-200355 · Cited by 268
Fujimoto, H., Sangai, T., Ishii, G., Ikehara, A., Nagashima, T., Miyazaki, M., & Ochiai, A. (2009) · International Journal of Cancer · doi:10.1002/ijc.24378 · Cited by 263
Nesbit, M., Schaider, H., Miller, T. H., & Herlyn, M. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.11.6483 · Cited by 235
Ding, T., Xu, J., Wang, F., Shi, M., Zhang, Y., Li, S.-P., & Zheng, L. (2009) · Human Pathology · doi:10.1016/j.humpath.2008.08.011 · Cited by 232
Zhou, Q., Peng, R.-Q., Wu, X.-J., Xia, Q., Hou, J.-H., Ding, Y., Zhou, Q.-M., Zhang, X., Pang, Z.-Z., Wan, D.-S., et al. (2010) · Journal of Translational Medicine · doi:10.1186/1479-5876-8-13 · Cited by 219
Self-citationMantovani, A. (1994) · PubMed · Cited by 204
Nonomura, N., Takayama, H., Nakayama, M., Nakai, Y., Kawashima, A., Mukai, M., Nagahara, A., Aozasa, K., & Tsujimura, A. (2011) · BJU International · doi:10.1111/j.1464-410x.2010.09804.x · Cited by 197
Fujii, N., Shomori, K., Shiomi, T., Nakabayashi, M., Takeda, C., Ryoke, K., & Ito, H. (2012) · Journal of Oral Pathology & Medicine · doi:10.1111/j.1600-0714.2012.01127.x · Cited by 191
Ohno, S., Ohno, Y., Suzuki, N., Kamei, T., Koike, K., Inagawa, H., Kohchi, C., Soma, G., & Inoue, M. (2004) · PubMed · Cited by 186
Stromal Macrophage Expressing CD204 is Associated with Tumor Aggressiveness in Lung Adenocarcinoma
Ohtaki, Y., Ishii, G., Nagai, K., Ashimine, S., Kuwata, T., Hishida, T., Nishimura, M., Yoshida, J., Takeyoshi, I., & Ochiai, A. (2010) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e3181eba692 · Cited by 185
Salvesen, H. B., & Akslen, L. A. (1999) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19991022)84:5<538::aid-ijc17>3.0.co;2-b · Cited by 182
Ohno, S., Inagawa, H., Dhar, D. K., Fujii, T., Ueda, S., Tachibana, M., Suzuki, N., Inoue, M., Soma, G., & Nagasue, N. (2003) · PubMed · Cited by 171
Khorana, A. A., Ryan, C., Cox, C., Eberly, S. W., & Sahasrabudhe, D. M. (2003) · Cancer · doi:10.1002/cncr.11152 · Cited by 170
Takanami, I., Takeuchi, K., & Kodaira, S. (1999) · Oncology · doi:10.1159/000012021 · Cited by 165
Marcus, B., Arenberg, D., Lee, J., Kleer, C., Chepeha, D. B., Schmalbach, C. E., Islam, M., Paul, S., Pan, Q., Hanash, S., et al. (2004) · Cancer · doi:10.1002/cncr.20701 · Cited by 163
Ju, M., Qiu, S., Fan, J., Xiao, Y., Gao, Q., Zhou, J., Li, Y.-W., & Tang, Z. (2009) · American Journal of Clinical Pathology · doi:10.1309/ajcp86ppbngohnnl · Cited by 157
Haas, M., Dimmler, A., Hohenberger, W., Grabenbauer, G. G., Niedobitek, G., & Distel, L. V. (2009) · BMC Gastroenterology · doi:10.1186/1471-230x-9-65 · Cited by 154
Valković, T., Dobrila, F., Melato, M., Sasso, F., Rizzardi, C., & Jonjić, N. (2001) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s004280100458 · Cited by 154
Tumor-associated macrophage (TAM) infiltration in gastric cancer.
Ishigami, S., Natsugoe, S., Tokuda, K., Nakajo, A., Okumura, H., Matsumoto, M., Miyazono, F., Hokita, S., & Aikou, T. (2003) · PubMed · Cited by 138
Wang, R., Lu, M., Chen, H., Chen, S., Luo, X., Qin, Y., & Zhang, J. (2011) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/1756-9966-30-62 · Cited by 138
Expression of monocyte chemotactic protein-1 in human invasive ductal breast cancer
Valković, T., Lučin, K., Krstulja, M., Dobi-Babić, R., & Jonjić, N. (1998) · Pathology - Research and Practice · doi:10.1016/s0344-0338(98)80057-5 · Cited by 137
Takayama, H., Nishimura, K., Tsujimura, A., Nakai, Y., Nakayama, M., Aozasa, K., Okuyama, Ä., & Nonomura, N. (2009) · The Journal of Urology · doi:10.1016/j.juro.2008.11.090 · Cited by 134
Zhang, B. C., Gao, J., Wang, J., Rao, Z. G., Wang, B. C., & Gao, J. F. (2010) · Medical Oncology · doi:10.1007/s12032-010-9638-5 · Cited by 134
Macrophages direct tumour histology and clinical outcome in a colon cancer model
Oosterling, S. J., van der Bij, G. J., Meijer, G. A., Tuk, C. W., van Garderen, E., van Rooijen, N., Meijer, S., van der Sijp, J. R., Beelen, R. H. J., & van Egmond, M. (2005) · The Journal of Pathology · doi:10.1002/path.1830 · Cited by 130
Bacman, D., Merkel, S., Croner, R. S., Papadopoulos, T., Brueckl, W. M., & Dimmler, A. W. (2007) · BMC Cancer · doi:10.1186/1471-2407-7-156 · Cited by 126
Bolat, F. A., Kayaselçuk, F., Nursal, T. Z., Yağmurdur, M. C., Bal, N., & Demirhan, B. (2006) · PubMed · Cited by 122
Macrophage expression of interleukin-10 is a prognostic factor in nonsmall cell lung cancer
Zeni, E., Mazzetti, L., Miotto, D., Cascio, N. L., Maestrelli, P., Querzoli, P., Pedriali, M., Rosa, E. D., Fabbri, L. M., Mapp, C. E., et al. (2007) · European Respiratory Journal · doi:10.1183/09031936.00129306 · Cited by 119
Circulating and Tumor-Infiltrating Myeloid Cells Predict Survival in Human Pleural Mesothelioma
Burt, B. M., Rodig, S. J., Tilleman, T. R., Elbardissi, A. W., Bueno, R., & Sugarbaker, D. J. (2011) · Cancer · doi:10.1002/cncr.26143 · Cited by 115
Tumor-Associated Macrophages as Incessant Builders and Destroyers of the Cancer Stroma
Liguori, M., Solinas, G., Germano, G., Mantovani, A., & Allavena, P. (2011) · Cancers · doi:10.3390/cancers3043740 · Cited by 115
Involvement of inflammatory mediators in macrophage antitumor activity
Bonta, I. L., & Ben‐Efraim, S. (1993) · Journal of Leukocyte Biology · doi:10.1002/jlb.54.6.613 · Cited by 114
Liu, S.-Y., Chang, L., Pan, L.-F., Hung, Y.-J., Lee, C.-H., & Shieh, Y. (2007) · Oral Oncology · doi:10.1016/j.oraloncology.2007.02.007 · Cited by 110
Prognostic significance of cell infiltrations of immunosurveillance in colorectal cancer
Tan, S.-Y. (2005) · World Journal of Gastroenterology · doi:10.3748/wjg.v11.i8.1210 · Cited by 108
Kurahara, H., Takao, S., Kuwahata, T., Nagai, T., Ding, Q., Maeda, K., Shinchi, H., Mataki, Y., Maemura, K., Matsuyama, T., et al. (2012) · Annals of Surgical Oncology · doi:10.1245/s10434-012-2263-0 · Cited by 104
Al-Shibli, K. I., Al‐Saad, S., Dønnem, T., Persson, M., Bremnes, R. M., & Busund, L. (2009) · Histopathology · doi:10.1111/j.1365-2559.2009.03379.x · Cited by 103
Chai, C.-Y., Chen, W.-T., Hung, W., Kang, W., Huang, Y.-C., Su, Y., & Yang, C.-H. (2007) · Journal of Clinical Pathology · doi:10.1136/jcp.2007.050666 · Cited by 98
Osinsky, S., Bubnovskaya, L., Ganusevich, І. І., Kovelskaya, A., Gumenyuk, L., Olijnichenko, G. P., & Merentsev, S. (2011) · Clinical & Translational Oncology · doi:10.1007/s12094-011-0630-0 · Cited by 85
Soeda, S., Nakamura, N., OOZEKI, T., Nishiyama, H., Hojo, H., Yamada, H., Abe, M., & Sato, A. (2008) · Gynecologic Oncology · doi:10.1016/j.ygyno.2007.12.033 · Cited by 83
Espinosa, Í., Carnicer, M. J., Catasús, L., Canet, B., D′Angelo, E., Zannoni, G. F., & Prat, J. (2010) · The American Journal of Surgical Pathology · doi:10.1097/pas.0b013e3181f32168 · Cited by 82
Li, Y.-W., Qiu, S., Fan, J., Gao, Q., Zhou, J., Xiao, Y., Xu, Y., Wang, X., Sun, J., & Huang, X. (2008) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-008-0469-0 · Cited by 75
Self-citationOhba, K., Miyata, Y., Kanda, S., Koga, S., Hayashi, T., & Kanetake, H. (2005) · The Journal of Urology · doi:10.1097/01.ju.0000165150.46006.92 · Cited by 66
Lin, J., Li, X., Tadashi, N., & Dong, P. (2011) · 癌症:英文版 · doi:10.5732/cjc.010.10336 · Cited by 64
Significance of thymidine phosphorylase as a marker of protumor monocytes in breast cancer.
Toi, M., Ueno, T., Matsumoto, H., Saji, H., Funata, N., Koike, M., & Tominaga, T. (1999) · PubMed · Cited by 63
Kawahara, A. (2010) · Oncology Reports · doi:10.3892/or_00000873 · Cited by 61
Kawanaka, T., Kubo, A., Ikushima, H., Sano, T., Takegawa, Y., & Nishitani, H. (2008) · The Journal of Medical Investigation · doi:10.2152/jmi.55.78 · Cited by 45
Macrophage infiltration and angiogenesis in endometrial cancer.
Hashimoto, I., Kodama, J., Seki, N., Hongo, A., Miyagi, Y., Yoshinouchi, M., & Kudo, T. (2000) · PubMed · Cited by 45
CSF1 Expression in Nongynecological Leiomyosarcoma Is Associated with Increased Tumor Angiogenesis
Espinosa, Í., Edris, B., Lee, C., Cheng, H. W., Gilks, C. B., Wang, Y. Z., Montgomery, K. D., Varma, S., Li, R., Marinelli, R. J., et al. (2011) · American Journal Of Pathology · doi:10.1016/j.ajpath.2011.06.021 · Cited by 40
Characterization of macrophage subpopulations in colon cancer using tissue microarrays
Sickert, D., Aust, D. E., Langer, S., Haupt, I., Baretton, G. B., & Dieter, P. (2005) · Histopathology · doi:10.1111/j.1365-2559.2005.02129.x · Cited by 36
Guo, S., Lin, D., Li, J., Liu, R.-Z., Zhou, C.-X., Wang, D.-M., Ma, W., Zhang, Y.-H., & Zhang, S.-R. (2007) · Diseases of the Esophagus · doi:10.1111/j.1442-2050.2007.00655.x · Cited by 32
Tanaka, Y., Kobayashi, H., Suzuki, M., Kanayama, N., Suzuki, M., & Terao, T. (2004) · Gynecologic Oncology · doi:10.1016/j.ygyno.2004.06.012 · Cited by 30
Ávila‐Moreno, F., López-González, J. S., Galindo-Rodrı́guez, G., Prado-Garcı́a, H., Bajaña, S., & Sánchez‐Torres, C. (2005) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-005-0060-3 · Cited by 28
Presence and quantification of macrophages in squamous cell carcinoma of the cervix
Heller, D. S., hameed, M., Cracchiolo, B. M., wiederkehr, M., Scott, D., Skurnick, J., ammar, N., & Lambert, W. C. (2003) · International Journal of Gynecological Cancer · doi:10.1046/j.1525-1438.2003.13035.x · Cited by 24
Cited by
Tumour-associated macrophages as treatment targets in oncology
Mantovani, A., Marchesi, F., Malesci, A., Laghi, L., & Allavena, P. (2017) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2016.217 · Cited by 4,033
Macrophages as regulators of tumour immunity and immunotherapy
DeNardo, D. G., & Ruffell, B. (2019) · Nature Reviews Immunology · doi:10.1038/s41577-019-0127-6 · Cited by 2,528
Roles of the immune system in cancer: From tumor initiation to metastatic progression
Gonzalez, H., Hagerling, C., & Werb, Z. (2018) · Genes & Development · doi:10.1101/gad.314617.118 · Cited by 2,111
Targeting macrophages: therapeutic approaches in cancer
Cassetta, L., & Pollard, J. W. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2018.169 · Cited by 2,048
Macrophages as tools and targets in cancer therapy
Mantovani, A., Allavena, P., Marchesi, F., & Garlanda, C. (2022) · Nature Reviews Drug Discovery · doi:10.1038/s41573-022-00520-5 · Cited by 1,807
Metadata
- Authors
- Zhang, Q.-W., Liu, L., Gong, C.-Y., Shi, H.-S., Zeng, Y.-H., Wang, X.-Z., Zhao, Y.-W., & Wei, Y.-Q.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2012-12-28
- Volume
- 7
- Issue
- 12
- Pages
- e50946
- ISSN
- 1932-6203 (ISSN-L)
- OpenAlex
- W2159999569
- Cited by
- 1,039
- References
- 80
- FWCI
- 2.07
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.